GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 34.13B |
| Revenue (ttm) | 19.97B |
| Net Income (ttm) | 2.24B |
| Shares Out | 456.56M |
| EPS (ttm) | 4.88 |
| PE Ratio | 15.34 |
| Forward PE | 16.21 |
| Dividend | $0.14 (0.18%) |
| Ex-Dividend Date | Jul 25, 2025 |
| Volume | 1,394,667 |
| Open | 76.99 |
| Previous Close | 76.63 |
| Day's Range | 74.89 - 77.05 |
| 52-Week Range | 57.65 - 94.80 |
| Beta | 1.28 |
| Analysts | Strong Buy |
| Price Target | 89.00 (+19.06%) |
| Earnings Date | Oct 29, 2025 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther... [Read more]
Financial Performance
In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for GEHC stock is "Strong Buy." The 12-month stock price target is $89.0, which is an increase of 19.06% from the latest price.
News
GE Healthcare exploring stake sale in China unit, Bloomberg News reports
Medical device maker GE Healthcare is working with advisers to explore options including the sale of a stake in its China unit, Bloomberg News reported on Thursday, citing people familiar with the mat...
GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neuro...
GE HealthCare Technologies Inc. (GEHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Peter Arduini - President, CEO & Director Caro...
GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare and CDL Nuclear Technologies Group enter agreement to distribute Flyrcado to CDL customer sites around the U.S.
GE HealthCare Technologies Inc. (GEHC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:45 AM EDT Company Participants James Saccaro - VP & CFO Carolynne Borders - Chief ...
GE HealthCare unveils Vivid Pioneer, its most advanced AI-powered cardiovascular ultrasound system, designed to enhance speed and image quality for improved diagnostic confidence and workflow efficiency
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely ...
GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
CHICAGO--(BUSINESS WIRE)--Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to en...
GE HealthCare management to present at upcoming investor conferences
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. 2025 Wells Fargo Healthcare Confer...
GE HealthCare: This Drop Represents A Buying Opportunity
GE HealthCare Technologies delivered strong Q2 results, beating revenue and earnings expectations, and raised full-year guidance despite a sharp share price drop. The company is trading at a significa...
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP...
GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
GE HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year.
GE HealthCare raises annual profit forecast on smaller tariff impact
GE HealthCare Technologies raised annual profit forecast on Wednesday, as the medical device maker expects a smaller hit from tariffs.
GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.
Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.
GE HealthCare reports second quarter 2025 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We were pleased...
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high-i...
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 liste...
GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom
GE HealthCare Technologies is one of the leaders in the healthcare sector, with a strong position in the global molecular imaging market. GE HealthCare's Pharmaceutical Diagnostics segment's EBIT was ...
GE HealthCare to announce second quarter 2025 results on July 30, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team wi...
GE HealthCare announces cash dividend for second quarter of 2025
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 pay...
FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--FDA approves expanded indications for GE HealthCare's Vizamyl PET imaging agent for beta amyloid detection, enabling more precise care for Alzheimer's.
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare's commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week's Society of Nuclear Medic...
GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As
GE Healthcare is well-positioned for growth, driven by a strong backlog, product innovation, and potential pent-up demand in China as stimulus funding is deployed. Margin headwinds from tariffs are ex...
GE HealthCare drives innovation in theranostics with latest technological advances
CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfo...
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions...
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare's proprietary features and algorithms with MIM Encore, marking a significant milestone in its ...